Breaking News Instant updates and real-time market news.

SMH

Market Vectors Semiconductor

$248.97 /

+5.66 (+2.33%)

08:21
04/26/21
04/26
08:21
04/26/21
08:21

Market Vectors Semiconductor: Pivot points

The following are the pivot points for the Market Vectors Semiconductor (SMH). Pivot High: $251.965, Pivot Low: $246.875. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.

TODAY'S FREE FLY STORIES

Upgrade
Citi upgrades Upstart to Buy on resumption after 55% selloff » 07:18
12/03/21
12/03
07:18
12/03/21
07:18
UPST

Upstart

$176.65 /

-3.1 (-1.72%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

07:05 Today Citi
Upstart upgraded to Buy from Neutral at Citi
11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
10/26/21
Fly Intel: Top five analyst downgrades
10/26/21 Jefferies
Jefferies downgrades Upstart to Hold, doubles target to $330
UPST Upstart
$176.65 /

-3.1 (-1.72%)

  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

Hot Stocks
Hagerty to begin trading on NYSE on December 3 » 07:17
12/03/21
12/03
07:17
12/03/21
07:17
HGTY

Hagerty

$10.89 /

+0.735 (+7.24%)

, ADF

Aldel Financial

/

+

Hagerty (HGTY) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HGTY Hagerty
$10.89 /

+0.735 (+7.24%)

ADF Aldel Financial
/

+

Recommendations
Marvell price target raised to $98 from $85 at BMO Capital » 07:14
12/03/21
12/03
07:14
12/03/21
07:14
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

07:10 Today Goldman Sachs
Goldman admits to being wrong to stay on sidelines, upgrades Marvell to Buy
07:06 Today Goldman Sachs
Marvell upgraded to Buy from Neutral at Goldman Sachs
06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
06:38 Today Credit Suisse
Marvell price target raised to $105 from $85 at Credit Suisse
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Recommendations
Kroger price target raised to $41 from $39 at BMO Capital » 07:11
12/03/21
12/03
07:11
12/03/21
07:11
KR

Kroger

$44.61 /

+4.4 (+10.94%)

BMO Capital analyst Kelly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

06:43 Today Deutsche Bank
Kroger price target raised to $45 from $43 at Deutsche Bank
06:28 Today Citi
Kroger price target raised to $47 from $43 at Citi
06:14 Today Barclays
Kroger price target raised to $38 from $37 at Barclays
11/03/21 Loop Capital
Loop Capital cuts Bed Bath & Beyond to Sell, cites deterioration in relevance
KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

KR Kroger
$44.61 /

+4.4 (+10.94%)

Hot Stocks
Xenon Pharmaceuticals presents additional data from Phase 2b X-TOLE trial » 07:10
12/03/21
12/03
07:10
12/03/21
07:10
XENE

Xenon Pharmaceuticals

$25.89 /

+0.065 (+0.25%)

Xenon Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$25.89 /

+0.065 (+0.25%)

XENE Xenon Pharmaceuticals
$25.89 /

+0.065 (+0.25%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$25.89 /

+0.065 (+0.25%)

  • 06
    Oct
  • 10
    Mar
XENE Xenon Pharmaceuticals
$25.89 /

+0.065 (+0.25%)

Upgrade
Goldman admits to being wrong to stay on sidelines, upgrades Marvell to Buy » 07:10
12/03/21
12/03
07:10
12/03/21
07:10
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

07:06 Today Goldman Sachs
Marvell upgraded to Buy from Neutral at Goldman Sachs
06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
06:38 Today Credit Suisse
Marvell price target raised to $105 from $85 at Credit Suisse
06:36 Today Citi
Marvell price target raised to $87 from $70 at Citi
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Recommendations
Veeva price target lowered to $310 from $349 at Baird » 07:10
12/03/21
12/03
07:10
12/03/21
07:10
VEEV

Veeva

$262.17 /

-10.09 (-3.71%)

Baird analyst Joe Vruwink…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VEEV Veeva
$262.17 /

-10.09 (-3.71%)

VEEV Veeva
$262.17 /

-10.09 (-3.71%)

12/02/21 Needham
Veeva price target lowered to $327 from $385 at Needham
12/02/21 Baird
Veeva price target lowered to $310 from $349 at Baird
12/02/21 UBS
Veeva price target lowered to $290 from $320 at UBS
10/01/21 Stifel
Veeva assumed with a Buy at Stifel
VEEV Veeva
$262.17 /

-10.09 (-3.71%)

VEEV Veeva
$262.17 /

-10.09 (-3.71%)

VEEV Veeva
$262.17 /

-10.09 (-3.71%)

Recommendations
DocuSign price target lowered to $220 from $330 at Baird » 07:08
12/03/21
12/03
07:08
12/03/21
07:08
DOCU

DocuSign

$233.83 /

+2.77 (+1.20%)

Baird analyst William…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

06:36 Today Wedbush
DocuSign downgraded to Neutral from Outperform at Wedbush
06:36 Today JMP Securities
DocuSign price target lowered to $307 from $320 at JMP Securities
06:17 Today Citi
DocuSign price target lowered to $231 from $389 at Citi
04:47 Today Piper Sandler
DocuSign downgraded to Neutral from Overweight at Piper Sandler
DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

DOCU DocuSign
$233.83 /

+2.77 (+1.20%)

Hot Stocks
Aclaris Therapeutics publishes preclinical research on zunsemetinib » 07:06
12/03/21
12/03
07:06
12/03/21
07:06
ACRS

Aclaris Therapeutics

$12.64 /

+0.07 (+0.56%)

Aclaris Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACRS Aclaris Therapeutics
$12.64 /

+0.07 (+0.56%)

ACRS Aclaris Therapeutics
$12.64 /

+0.07 (+0.56%)

07/23/21 Jefferies
Aclaris Therapeutics assumed with a Buy at Jefferies
06/16/21 H.C. Wainwright
Aclaris Therapeutics price target raised to $50 from $40 at H.C. Wainwright
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Piper Sandler
Aclaris Therapeutics initiated with an Overweight at Piper Sandler
ACRS Aclaris Therapeutics
$12.64 /

+0.07 (+0.56%)

  • 10
    Jun
  • 20
    Jan
ACRS Aclaris Therapeutics
$12.64 /

+0.07 (+0.56%)

Upgrade
Marvell upgraded to Buy from Neutral at Goldman Sachs » 07:06
12/03/21
12/03
07:06
12/03/21
07:06
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

06:49 Today UBS
Marvell price target raised to $95 from $87 at UBS
06:38 Today Credit Suisse
Marvell price target raised to $105 from $85 at Credit Suisse
06:36 Today Citi
Marvell price target raised to $87 from $70 at Citi
06:10 Today Deutsche Bank
Marvell price target raised to $100 from $76 at Deutsche Bank
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Recommendations
GMS Inc. price target raised to $68 from $62 at Baird » 07:05
12/03/21
12/03
07:05
12/03/21
07:05
GMS

GMS Inc.

$57.74 /

+1.36 (+2.41%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

06:14 Today Barclays
GMS Inc. price target raised to $61 from $56 at Barclays
09/08/21 Barclays
GMS Inc. price target raised to $56 from $49 at Barclays
09/03/21 Truist
GMS Inc. price target raised to $62 from $52 at Truist
09/03/21 Baird
GMS Inc. price target raised to $62 from $58 at Baird
GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

GMS GMS Inc.
$57.74 /

+1.36 (+2.41%)

Upgrade
Upstart upgraded to Buy from Neutral at Citi » 07:05
12/03/21
12/03
07:05
12/03/21
07:05
UPST

Upstart

$176.65 /

-3.1 (-1.72%)

Citi analyst Peter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

11/10/21 Piper Sandler
Upstart should be bought on earnings selloff, says Piper Sandler
10/26/21
Fly Intel: Top five analyst downgrades
10/26/21 Jefferies
Jefferies downgrades Upstart to Hold, doubles target to $330
10/26/21 Jefferies
Upstart downgraded to Hold from Buy at Jefferies
UPST Upstart
$176.65 /

-3.1 (-1.72%)

  • 16
    Jun
  • 09
    Apr
  • 16
    Dec
UPST Upstart
$176.65 /

-3.1 (-1.72%)

UPST Upstart
$176.65 /

-3.1 (-1.72%)

Hot Stocks
Limbach Holding acquires Jake Marshall for $20M in cash » 07:05
12/03/21
12/03
07:05
12/03/21
07:05
LMB

Limbach Holding

$6.53 /

-0.32 (-4.67%)

Limbach Holding announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LMB Limbach Holding
$6.53 /

-0.32 (-4.67%)

LMB Limbach Holding
$6.53 /

-0.32 (-4.67%)

08/13/21 Lake Street
Limbach Holding price target raised to $21 from $19 at Lake Street
03/05/21
Fly Intel: Top five analyst initiations
03/05/21 Lake Street
Limbach Holding initiated with a Buy at Lake Street
LMB Limbach Holding
$6.53 /

-0.32 (-4.67%)

  • 11
    Feb
LMB Limbach Holding
$6.53 /

-0.32 (-4.67%)

Hot Stocks
Amicus announces EMA validated MAA for AT-GAA » 07:04
12/03/21
12/03
07:04
12/03/21
07:04
FOLD

Amicus

$11.13 /

+0.385 (+3.58%)

Amicus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FOLD Amicus
$11.13 /

+0.385 (+3.58%)

FOLD Amicus
$11.13 /

+0.385 (+3.58%)

11/15/21 Stifel
Amicus upgraded to Buy from Hold at Stifel
09/30/21
Fly Intel: Top five analyst upgrades
09/30/21 Cowen
Amicus spin-out and profit potential makes it takeout target, says Cowen
09/30/21 JPMorgan
Amicus upgraded to Overweight from Neutral at JPMorgan
FOLD Amicus
$11.13 /

+0.385 (+3.58%)

FOLD Amicus
$11.13 /

+0.385 (+3.58%)

Initiation
Baird start Vor Biopharma with an Outperform ahead of AML data » 07:04
12/03/21
12/03
07:04
12/03/21
07:04
VOR

Vor Biopharma

$13.08 /

+1.71 (+15.04%)

As reported previously,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

12/02/21 Baird
Vor Biopharma initiated with an Outperform at Baird
12/01/21 Oppenheimer
Vor Biopharma initiated with an Outperform at Oppenheimer
10/19/21 JMP Securities
Vor Biopharma initiated with an Outperform at JMP Securities
07/08/21 Stifel
Vor Biopharma, Janssen collaboration benefits both parties, says Stifel
VOR Vor Biopharma
$13.08 /

+1.71 (+15.04%)

  • 05
    Feb
Hot Stocks
BioCryst reports inducement grants under Nasdaq listing rule » 07:04
12/03/21
12/03
07:04
12/03/21
07:04
BCRX

BioCryst

$11.86 /

+0.58 (+5.14%)

BioCryst Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCRX BioCryst
$11.86 /

+0.58 (+5.14%)

BCRX BioCryst
$11.86 /

+0.58 (+5.14%)

11/22/21 Piper Sandler
BioCryst financing lifts one of two overhangs, says Piper Sandler
11/04/21 Barclays
BioCryst price target lowered to $17 from $21 at Barclays
11/03/21 Piper Sandler
BioCryst earnings pullback a buying opportunity, says Piper Sandler
08/06/21 Jefferies
BioCryst downgraded to Hold from Buy at Jefferies
BCRX BioCryst
$11.86 /

+0.58 (+5.14%)

  • 11
    Aug
BCRX BioCryst
$11.86 /

+0.58 (+5.14%)

BCRX BioCryst
$11.86 /

+0.58 (+5.14%)

Recommendations
Ooma price target raised to $27 from $26 at Alliance Global Partners » 07:03
12/03/21
12/03
07:03
12/03/21
07:03
OOMA

Ooma

$19.05 /

+0.23 (+1.22%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

09/03/21 B. Riley
Ooma price target raised to $27.50 from $24 at B. Riley
09/03/21 Benchmark
Ooma price target raised to $30 from $27 at Benchmark
09/03/21 JMP Securities
Ooma price target raised to $27 from $22 at JMP Securities
05/27/21 B. Riley
Ooma price target raised to $24 from $23.50 at B. Riley
OOMA Ooma
$19.05 /

+0.23 (+1.22%)

OOMA Ooma
$19.05 /

+0.23 (+1.22%)

Hot Stocks
Compass Pathways appoints Michael Falvey as Chief Financial Officer » 07:03
12/03/21
12/03
07:03
12/03/21
07:03
CMPS

Compass Pathways

$31.95 /

+ (+0.00%)

, KPTI

Karyopharm

$7.26 /

+0.57 (+8.52%)

COMPASS Pathways (CMPS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMPS Compass Pathways
$31.95 /

+ (+0.00%)

KPTI Karyopharm
$7.26 /

+0.57 (+8.52%)

CMPS Compass Pathways
$31.95 /

+ (+0.00%)

11/11/21 Roth Capital
Atai Life Sciences initiated with a Buy at Roth Capital
11/09/21 Citi
Citi says Compass Pathways selloff overdone, ups price target to $70
11/09/21 Cantor Fitzgerald
Compass Pathways price target raised to $82 from $71 at Cantor Fitzgerald
11/09/21 Roth Capital
Compass Pathways price target raised to $117 from $79 at Roth Capital
KPTI Karyopharm
$7.26 /

+0.57 (+8.52%)

11/19/21 Morgan Stanley
Karyopharm assumed at Equal Weight from Overweight at Morgan Stanley
08/06/21 JPMorgan
JPMorgan double downgrades Karyopharm on Xpovio weakness
08/06/21 Baird
Karyopharm price target lowered to $17 from $30 at Baird
08/06/21 SVB Leerink
Karyopharm downgraded to Market Perform from Outperform at SVB Leerink
CMPS Compass Pathways
$31.95 /

+ (+0.00%)

KPTI Karyopharm
$7.26 /

+0.57 (+8.52%)

  • 30
    Apr
CMPS Compass Pathways
$31.95 /

+ (+0.00%)

CMPS Compass Pathways
$31.95 /

+ (+0.00%)

KPTI Karyopharm
$7.26 /

+0.57 (+8.52%)

CMPS Compass Pathways
$31.95 /

+ (+0.00%)

Hot Stocks
Enochian Biosciences presents human, lab data on treating solid tumors » 07:02
12/03/21
12/03
07:02
12/03/21
07:02
ENOB

Enochian Biosciences

$11.52 /

+0.045 (+0.39%)

Enochian BioSciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENOB Enochian Biosciences
$11.52 /

+0.045 (+0.39%)

ENOB Enochian Biosciences
$11.52 /

+0.045 (+0.39%)

ENOB Enochian Biosciences
$11.52 /

+0.045 (+0.39%)

Hot Stocks
Bristol-Myers: FDA accepts for priority review sBLA for Reblozyl » 07:00
12/03/21
12/03
07:00
12/03/21
07:00
BMY

Bristol-Myers

$55.41 /

+0.46 (+0.84%)

, MRK

Merck

$73.89 /

-0.54 (-0.73%)

Bristol Myers Squibb…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

11/23/21 Societe Generale
Societe Generale upgrades AbbVie to Buy on better than anticipated execution
11/18/21 BMO Capital
Bristol-Myers initiated with an Outperform at BMO Capital
11/15/21 Evercore ISI
Ventyx Biosciences initiated with an Outperform at Evercore ISI
11/15/21 Jefferies
Jefferies starts Ventyx at Buy based on blockbuster potential
MRK Merck
$73.89 /

-0.54 (-0.73%)

11/29/21
Fly Intel: Top five analyst downgrades
11/29/21 Morgan Stanley
Merck price target lowered to $82 from $88 at Morgan Stanley
11/29/21 Morgan Stanley
Pfizer price target raised to $60 from $50 at Morgan Stanley
11/29/21 Citi
Merck downgraded to Neutral from Buy at Citi
BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

BMY Bristol-Myers
$55.41 /

+0.46 (+0.84%)

MRK Merck
$73.89 /

-0.54 (-0.73%)

Upgrade
PNM Resources upgraded to Equal Weight on valuation at Wells Fargo » 07:00
12/03/21
12/03
07:00
12/03/21
07:00
PNM

PNM Resources

$45.18 /

-3.05 (-6.32%)

, AGR

Avangrid

$49.47 /

-1.4 (-2.75%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PNM PNM Resources
$45.18 /

-3.05 (-6.32%)

AGR Avangrid
$49.47 /

-1.4 (-2.75%)

PNM PNM Resources
$45.18 /

-3.05 (-6.32%)

12/02/21 Wells Fargo
PNM Resources upgraded to Equal Weight from Underweight at Wells Fargo
08/25/21 Argus
PNM Resources downgraded to Hold from Buy at Argus
08/24/21 Mizuho
Avangrid price target raised to $53 from $51 at Mizuho
03/03/21 Citi
PNM Resources downgraded to Neutral from Buy at Citi
AGR Avangrid
$49.47 /

-1.4 (-2.75%)

08/25/21 Argus
PNM Resources downgraded to Hold from Buy at Argus
08/24/21 Mizuho
Avangrid price target raised to $53 from $51 at Mizuho
07/23/21 Mizuho
Avangrid price target lowered to $51 from $52 at Mizuho
05/20/21
Fly Intel: Top five analyst initiations
PNM PNM Resources
$45.18 /

-3.05 (-6.32%)

AGR Avangrid
$49.47 /

-1.4 (-2.75%)

PNM PNM Resources
$45.18 /

-3.05 (-6.32%)

AGR Avangrid
$49.47 /

-1.4 (-2.75%)

Recommendations
Ulta Beauty price target raised to $480 from $460 at Baird » 06:59
12/03/21
12/03
06:59
12/03/21
06:59
ULTA

Ulta Beauty

$383.13 /

+12.8 (+3.46%)

Baird analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

06:43 Today Deutsche Bank
Ulta Beauty price target raised to $506 from $483 at Deutsche Bank
06:24 Today Citi
Ulta Beauty price target raised to $430 from $375 at Citi
06:05 Today Piper Sandler
Ulta Beauty price target raised to $475 from $433 at Piper Sandler
10/20/21 Cowen
Ulta Beauty price target lowered to $440 from $490 at Cowen
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

Initiation
Benchmark starts Old Dominion at Hold, sees other LTL carriers closing gap » 06:58
12/03/21
12/03
06:58
12/03/21
06:58
ODFL

Old Dominion

/

+

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ODFL Old Dominion
/

+

ODFL Old Dominion
/

+

06:11 Today Benchmark
Old Dominion initiated with a Hold at Benchmark
11/30/21 KeyBanc
Old Dominion price target raised to $375 from $350 at KeyBanc
11/16/21 UBS
Old Dominion downgraded to Neutral from Buy at UBS
11/09/21 Morgan Stanley
Morgan Stanley cuts Old Dominion to Equal Weight, thinks bar may be too high
ODFL Old Dominion
/

+

Downgrade
Wells Fargo downgrades Joann after second straight comp miss » 06:58
12/03/21
12/03
06:58
12/03/21
06:58
JOAN

Joann

$9.34 /

+0.68 (+7.85%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

05:36 Today Wells Fargo
Joann downgraded to Equal Weight from Overweight at Wells Fargo
10/01/21 Barclays
Joann downgraded to Underweight from Equal Weight at Barclays
09/20/21 Loop Capital
Joann's updated format easier to shop, says Loop Capital
09/07/21 Loop Capital
Joann price target lowered to $15 from $20 at Loop Capital
JOAN Joann
$9.34 /

+0.68 (+7.85%)

  • 12
    Mar
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

Recommendations
Duluth Holdings price target raised to $28 from $22 at Baird » 06:56
12/03/21
12/03
06:56
12/03/21
06:56
DLTH

Duluth Holdings

$16.09 /

+2.495 (+18.36%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DLTH Duluth Holdings
$16.09 /

+2.495 (+18.36%)

09/03/21 Baird
Duluth Holdings added to bullish Fresh Pick at Baird
06/02/21 Baird
Duluth Holdings a strong recovery play, says Baird
12/14/20 Stifel
Duluth Holdings upgraded to Buy from Hold at Stifel
12/04/20 Baird
Duluth Holdings elevated to Fresh Pick at Baird
DLTH Duluth Holdings
$16.09 /

+2.495 (+18.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.